Clinical Trial Update: EPO906 Therapy in Patients With Prostate Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating EPO906 therapy in prostate cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• EPO906

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Prostatic Neoplasms | Phase 2 | Status: COMPLETED